Planned post-chemoradiation neck dissection: Significance of radiation dose

Laryngoscope

Volumn 116, Issue 1, 2006, Pages 33-36

  Stenson, Kerstin M ^a   Huo, Dezheng ^a   Blair, Elizabeth ^a   Cohen, Ezra E W ^a   Argiris, Athanassios ^b   Haraf, Daniel J ^a   Vokes, E Everett ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; HYDROXYUREA; PACLITAXEL; ANTINEOPLASTIC AGENT;

CONTROLLED STUDY; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; NECK DISSECTION; PRIORITY JOURNAL; RADIATION DOSE; REVIEW; RISK ASSESSMENT; TREATMENT PLANNING; WOUND HEALING IMPAIRMENT; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER STAGING; CASE CONTROL STUDY; COMPARATIVE STUDY; CONFIDENCE INTERVAL; FEMALE; FOLLOW UP; HEAD AND NECK TUMOR; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY; NONPARAMETRIC TEST; PATHOLOGY; PREOPERATIVE CARE; PROBABILITY; REGISTER; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; SURVIVAL; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CHEMOTHERAPY, ADJUVANT; CONFIDENCE INTERVALS; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NECK DISSECTION; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREOPERATIVE CARE; PROBABILITY; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33645243420     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mlg.0000185846.27617.fe     Document Type: Review

References (13)

1. Vokes EE, Stenson K, Rosen FR, et al. Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancer. J Clin Oncol 2003;21:320-326.
2. Haraf DJ, Rosen FR, Stenson K, et al. Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancer. Clin Cancer Res 2003;9:5936-5943.
3. Gustin D, Haraf D, Stenson K, et al. Induction chemotherapy followed by concomitant chemoradiation for patients with advanced head and neck cancer. Pro Am Soc Clin Oncol 2004;22(14S);499S; Abstract 5546.
4. Stenson KM, Haraf DJ, Pelzer H, et al. The role of cervical lymphadenectomy after aggressive concomitant chemoradiotherapy. Arch Otolaryngol Head Neck Surg 2000;126:950-956.
5. Robbins TK, Ferlito A, Suarez C, et al. Is there a role for selective dissection after chemoradiation for head and neck cancer? J Am Coll Surg 2004;199:913-916.
6. McHam SA, Adelstein DJ, Rybicki LA, et al. Who merits a neck dissection after definitive chemoradiotherapy for N2-N3 squamous cell head and neck cancer? Head Neck 2003;791-798.
7. Corry J, Smith JG, Peters LJ. The concept of a planned neck dissection is obsolete. Cancer J 2001;7:472-474.
8. Athanassios A, Stenson KM, Brockstein BE, et al. Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer. Head Neck 2004;26:447-455.
9. Ampil FL, Mills GM, Caldito G, et al. Induction chemotherapy followed by concomitant chemoradiation-induced regression of advanced cervical lymphadenopathy in head and neck cancer as a predictor of outcome. Otolaryngol Head Neck Surg 2002;126:602-606.
10. Velazquez RA, McGuff SH, Sycamore D, Miller FR. The role of computed tomographic scans in the management of the N-positive neck in head and neck squamous cell carcinoma after chemoradiotherapy. Arch Otolaryngol Head Neck Surg 2004;130:74-77.
11. Frank DK, Hu KS, Culliney BE, et al. Planned neck dissection after concomitant radiochemotherapy for advanced head and neck cancer. Laryngoscope. 2005;115:1015-1020.
12. Moore MG, Bhattacharyya N. Effectiveness of chemotherapy and radiotherapy in sterilizing cervical nodal disease in squamous cell carcinoma of the head and neck. Laryngoscope 2005;115:570-573.
13. Strasser MD, Lyon GL, Miller MA, Saavedra HI, Gluckman JL. Management implications of evaluating the N2 and N3 neck after organ preservation therapy. Laryngoscope 1999;109:1776-1780.